Case Study

Rare Diseases Patient Support Program across multiple territories

MSdialog, a digital patient support program, was designed
to give multiple sclerosis (MS) patients control over the
management of their disease, in the administration of their
treatment in combination with a connected injection
device (RebiSmart), and facilitate meaningful dialogue
between patients and clinicians. Having been localized and
deployed in 39 countries, and supporting 40 languages, S3
Connected Health played a key role in design,
development and delivery of the mobile and web-based
system

The program

Deployed in 39 countries
Supporting 40 languages
Designed to support a large population of patients across multiple territories
Providing support for local care protocols
Providing real-world evidence for pharma client, payors, and HCPs
Designed to facilitate EHR and disease registry integration

Includes:

Connected injection device that communicates to patient interface / mobile app (RebiSmart)
System Includes: education and training, eTherapy, PSP integration, clinical support, treatment management, visiting nurse support
Reporting, insights, and business intelligence portal

The project

How it works
Key learnings
Key results

A connected injection device allows patients to self-inject and sends information wirelessly to each secure program server. The connected injection device records the date, time, and dosage of each injection so that an accurate dosing history can be discussed with a patient, allowing physicians to monitor and improve adherence to therapy.

The patient mobile app allows patients to provide feedback on their health and to track their own adherence and treatment progress. It also provides important economic and clinical real-world data, facilitating service planning and reconfiguration at country and regional levels.
Following launch, MSdialog and RebiSmart were localized and deployed in 39 countries, supporting 40 languages. Patients reported both the web-based software and the app to be easy to use, with ease of use increasing over a six-week study period.
Patients were highly committed to reporting
outcomes on a weekly or monthly basis.
- 87% of patients stated that completion of patient-reported outcomes with the program fitted in “fairly well” to “extremely well” with their weekly routine.
- 77% of patients were “extremely satisfied” or “very satisfied” with their digital patient support program experience at the end of week six.
- 82% considered it better than previous methods for tracking their health and 95% would recommend using the digital patient support program.
- Patients felt the digital patient support program helped them to actively engage in the management of their disease between consultations.